masthead-news

News & Events

HTG Molecular Diagnostics Reports First Quarter 2022 Results

Call scheduled for today, May 12, at 4:30 pm ET TUCSON, Ariz. , May 12, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported recent business…

Read More

Posted on:
 

HTG Expands Therapeutics Team

Christina M. Carruthers, Ph.D. Joins as Vice President of Target Strategy and Early Development TUCSON, Ariz. , April 13, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide…

Read More

Posted on:
 

HTG Expands Features of Proprietary HTG EdgeSeq Technology

New Sample Preparation Harmonization Designed to Enable miRNA and mRNA Profiling Without the Need for Additional Sample TUCSON, Ariz. , April 06, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative…

Read More

Posted on:
 

HTG Molecular Diagnostics Reports Full Year 2021 Results

Call scheduled for today, March 29, at 4:30 pm ET TUCSON, Ariz. , March 29, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its…

Read More

Posted on:
 

Page last updated August 23, 2022